KLAS-Therapeutics Ltd. are a biotechnology company founded in Northern Ireland in Feb. 2021 (Company Number NI676570). They have developed a new and innovative therapy for the treatment of non-resectable metastatic melanoma (MM), the most aggressive form of skin cancer. The technology originates from research carried out at the School of Pharmacy and Pharmaceutical Sciences at Ulster University. Using our proprietary technology (National phase in US and EU No 634817), we have unlocked the potential of photodynamic therapy (PDT) for MM with a comprehensive preclinical data set showing strong proof of principle evidence that has been both peer reviewed and award winning.